STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
“Camurus continues to make good progress with positive results from several clinical trials and a Phase 3 registration program in opioid addiction nearing completion.”
STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
“Camurus continues to make good progress with positive results from several clinical trials and a Phase 3 registration program in opioid addiction nearing completion.”
